Literature DB >> 4179532

Daunorubicin in acute myelocytic leukaemia.

J S Malpas, R B Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4179532     DOI: 10.1016/s0140-6736(69)91516-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

2.  Daunorubicin and the heart.

Authors: 
Journal:  Br Med J       Date:  1974-11-23

Review 3.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

4.  The persistence of adriamycin in man and rat.

Authors:  P M Wilkinson; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

5.  Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts.

Authors:  E Bachmann; E Weber; G Zbinden
Journal:  Agents Actions       Date:  1975-10

6.  Adriamycin in the treatment of acute leukaemia.

Authors:  J M Whitehouse; D Crowther; C J Bateman; M E Beard; J S Malpas
Journal:  Br Med J       Date:  1972-02-19

7.  Role of the sympathetic nervous system in daunomycin-induced arrhythmia in the monkey.

Authors:  B Burka; E Herman; J Vick
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

8.  Clinical evaluation of adriamycin, a new antitumour antibiotic.

Authors:  G Bonadonna; S Monfardini; M De Lena; F Fossati-Bellani
Journal:  Br Med J       Date:  1969-08-30

9.  Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.

Authors:  B J Smith; D Kundv
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.